HIV-1 GP120 V3 conformational and informational entropies

被引:1
|
作者
Weltman, JK [1 ]
Skowron, G
Loriot, GB
机构
[1] Brown Univ, Brown Med Sch, Dept Med, Providence, RI 02912 USA
[2] Brown Univ, Boston Univ, Sch Med, Providence, RI 02912 USA
[3] Brown Univ, Brown AIDS Program, Roger Williams Med Ctr, Providence, RI 02912 USA
[4] Brown Univ, Ctr Computat & Visualizat, Providence, RI 02912 USA
关键词
HIV-1; V3; loop; GP120; HF-SCF; entropy; energy; conformational entropy; informational entropy; Shannon entropy; entropy variance; molecular evolution;
D O I
10.1007/s00894-005-0054-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In an attempt to analyze structure, function and evolution of HIV-1 GP120 V3, interactions among the Hartree-Fock energy, the conformational entropy and the Shannon entropy were determined for the 1NJ0 set of antibody-bound V3 loop conformers. The Hartree-Fock energy of each conformer was determined at the MINI level with GAMESS. The conformational entropy was determined per conformer and per residue from the mass-weighted covariance matrices. The Shannon entropy per residue was determined from sequence-substitution frequencies. Correlations were determined by linear regression analysis. There was a negative correlation between the Hartree-Fock energy and the conformational entropy (R=-0.4840, p=0.0078, df =28) that enhanced the negative Helmholtz-free-energy change for the binding of the GP120 ligand to target CD4. The Shannon entropy of V3 was a function of the conformational entropy variance (R=0.7225, p=0.00157, df=15) and of the V3 Hartree-Fock energy. Biological implications of this work are that (1) conformational entropy interacts with V3 Hartree-Fock energy to enhance GP120 binding to CD4 cell receptors and that (2) the Hartree-Fock energy of V3 interacts with the evolutionary system to participate in the regulation of V3 diversity.
引用
收藏
页码:362 / 365
页数:4
相关论文
共 50 条
  • [21] SURAMIN INHIBITS BINDING OF THE V3 REGION OF HIV-1 ENVELOPE GLYCOPROTEIN GP120 TO GALACTOSYLCERAMIDE, THE RECEPTOR FOR HIV-1 GP120 ON HUMAN COLON EPITHELIAL-CELLS
    YAHI, N
    SABATIER, JM
    NICKEL, P
    MABROUK, K
    GONZALEZSCARANO, F
    FANTINI, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (39) : 24349 - 24353
  • [22] The mutual orientation between V1/V2 and V3 is the structural determinant of HIV-1 gp120 conformational states and dynamics
    Li, Yi
    Deng, Lei
    Tao, Yan
    Liu, Shu-Qun
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2019, 37 : 72 - 72
  • [23] V3 LOOP REGION OF THE HIV-1 GP120 ENVELOPE PROTEIN IS ESSENTIAL FOR VIRUS INFECTIVITY
    IVANOFF, LA
    DUBAY, JW
    MORRIS, JF
    ROBERTS, SJ
    GUTSHALL, L
    STERNBERG, EJ
    HUNTER, E
    MATTHEWS, TJ
    PETTEWAY, SR
    VIROLOGY, 1992, 187 (02) : 423 - 432
  • [24] EFFECT OF MUTATIONS IN THE V3 LOOP OF HIV-1 GP120 ON INFECTIVITY AND SUSCEPTIBILITY TO PROTEOLYTIC CLEAVAGE
    SCHULZ, TF
    REEVES, JD
    HOAD, JG
    TAILOR, C
    STEPHENS, P
    CLEMENTS, G
    ORTLEPP, S
    PAGE, KA
    MOORE, JP
    WEISS, RA
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (02) : 159 - 166
  • [25] THE HIV-1 V3 LOOP CONFORMATION AND ITS GP120 CONTEXT ARE BOTH IMPORTANT FOR NEUTRALIZATION
    ROBERTGUROFF, M
    MULDOON, R
    STERN, T
    ALDRICH, K
    LOUIE, A
    GROGG, D
    WHITESCHARF, M
    POTTS, B
    GALLO, RC
    REITZ, MS
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 679 - 679
  • [26] Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope
    Zolla-Pazner, Susan
    Cohen, Sandra Sharpe
    Krachmarov, Chavdar
    Wang, Shixia
    Pinter, Abraham
    Lu, Shan
    VIROLOGY, 2008, 372 (02) : 233 - 246
  • [27] ROLE OF THE HIV-1 GP120 DOMAINS V1, V2, AND V3 IN DETERMINING CYTOPATHOGENICITY
    GROENINK, M
    FOUCHIER, RAM
    BROERSEN, S
    BAKER, CH
    VANDERJAGT, RCM
    MIEDEMA, F
    HUISMAN, HG
    TERSMETTE, M
    SCHUITEMAKER, H
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 29 - 29
  • [28] Prediction of HIV-1 coreceptor usage based on structural descriptors of the gp120 V3 loop
    Sander, O.
    Sing, T.
    Sommer, I.
    Low, A. J.
    Cheung, P. K.
    Harrigan, P. R.
    Lengauer, T.
    Domingues, F. S.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S16 - S16
  • [29] Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing Fabs
    Stanfield, RL
    Cabezas, E
    Satterthwait, AC
    Stura, EA
    Profy, AT
    Wilson, IA
    STRUCTURE, 1999, 7 (02) : 131 - 142
  • [30] HIGH ANTIGENIC CROSS-REACTIVITY OF THE V3 CONSENSUS SEQUENCES OF HIV-1 GP120
    BAILLOU, A
    BRAND, D
    DENIS, F
    MBOUP, S
    CHOUT, R
    GOUDEAU, A
    BARIN, F
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (12) : 1209 - 1215